Facebook
X
LinkedIn
ForwardOptimizing Hormonal Health: Clinical Strategies in Bioidentical Hormone Replacement Therapy (BHRT)
This live activity provides an evidence-based review of hormone replacement therapy (HRT) and bioidentical hormone replacement therapy (BHRT) in male and female patients, including clinical indications, contraindications, treatment strategies, and monitoring protocols. Participants will examine the physiologic principles and historical evolution of HRT and BHRT, evaluate current evidence regarding safety, cancer risk, and outcomes, and discuss management of common complications such as aromatization, polycythemia, and mood or libido changes. The course also integrates adjunctive therapies and applies these concepts through real-world case studies across diverse age groups and comorbid conditions to support safe, effective clinical decision-making.
Target Audience
This activity is designed for an audience of physicians, physician assistants, nurse practitioners, nurses and any other healthcare professional interested in BHRT.
Learning Objectives
- Identify clinical indications, contraindications, and monitoring protocols for male and female hormone replacement therapy.
- Describe the physiologic principles and historical evolution of HRT and BHRT, including the rationale for bioidentical hormone use.
- Analyze current evidence regarding safety, cancer risk, and clinical outcomes associated with HRT and BHRT.
- Discuss common complications of HRT/BHRT—including aromatization, polycythemia, and mood or libido changes—and evidence-based management strategies.
- Integrate adjunctive therapies such as thyroid optimization, cortisol management, vitamin D3, and nutraceuticals into comprehensive hormone care.
- Evaluate real-world clinical scenarios using case-based discussions across age ranges and comorbid conditions.
Commercial Support
This activity is supported by an independent medical education grant and in-kind support from Next MD Link and Bella Vita Clinics.
DISCLOSURES | ||
Name | Relationship | Commercial Interest |
Elliot Lander, MD | Ownership interest
Executive role | Cell Surgical Network- stem cell
Bella Vita- hormones |
Dorothy Caputo, MA, BSN, RN President, AKH Inc., Advancing Knowledge in Healthcare | N/A | Nothing to disclose |
Bernadette Makar, MSN, APRN-BC, NP-C (planner/reviewer) | N/A | Nothing to disclose |
Rebecca Lakofsky, RN Planner/Reviewer | N/A | Nothing to disclose |
AKH Inc Staff and Planners | N/A | Nothing to disclose |
Revive Staff and Planners | N/A | Nothing to disclose |
All of the relevant financial relationships listed for these individuals have been mitigated. | ||
All of the relevant financial relationships listed for these individuals have been mitigated.
Disclosures
None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and REVIVE™ Institute and Training. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 16.25 Interprofessional Continuing Education (IPCE) credit for learning and change.
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 16.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity..
Nursing
Credit being awarded: 16.25 ANCC contact hours.
Physician Associates
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 16.25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Nurse Practitioners
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and REVIVE™ Institute and Training. AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 12.5 contact hour(s) (which includes 12.5 hour(s) of pharmacology).
The workshop with live injections is not accredited using AANP credit.
Available Credit
- 12.50 AANP
- 16.25 AAPA Category 1 CME
- 16.25 AMA PRA Category 1 Credit™
- 16.25 ANCC
- 16.25 Attendance